TrialThe New England journal of medicine2023
Two Phase 3 Trials of Gantenerumab in Early Alzheimer's Disease.
Randall J Bateman et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
191 papers cite itlatest 60 shown
this paperpooled ittrialcites it